[HTML][HTML] Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement
S Li, M Jiang, L Wang, S Yu - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Chemotherapy with a single chemotherapeutic agent or a combined chemotherapeutic
regimen is the clinically standardized treatment for almost all human cancers. Upregulated …
regimen is the clinically standardized treatment for almost all human cancers. Upregulated …
[引用][C] Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement
S Li, M Jiang, L Wang, S Yu - Biomedicine & Pharmacotherapy, 2020 - cir.nii.ac.jp
Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers:
Recent advancement | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …
Recent advancement | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …
Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement
S Li, M Jiang, L Wang, S Yu - Biomedicine & …, 2020 - pubmed.ncbi.nlm.nih.gov
Chemotherapy with a single chemotherapeutic agent or a combined chemotherapeutic
regimen is the clinically standardized treatment for almost all human cancers. Upregulated …
regimen is the clinically standardized treatment for almost all human cancers. Upregulated …
Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement.
S Li, M Jiang, L Wang, S Yu - Biomedicine & Pharmacotherapy …, 2020 - europepmc.org
Chemotherapy with a single chemotherapeutic agent or a combined chemotherapeutic
regimen is the clinically standardized treatment for almost all human cancers. Upregulated …
regimen is the clinically standardized treatment for almost all human cancers. Upregulated …